SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 7,338.94 |
| Enterprise Value ($M) | 7,005.39 |
| Book Value ($M) | 2,078.15 |
| Book Value / Share | 11.16 |
| Price / Book | 3.53 |
| NCAV ($M) | 1,847.38 |
| NCAV / Share | 9.92 |
| Price / NCAV | 3.97 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.32 |
| Return on Assets (ROA) | -0.37 |
| Return on Equity (ROE) | -0.40 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.46 |
| Current Ratio | 13.46 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2,134.58 |
| Assets | 2,365.35 |
| Liabilities | 287.20 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -689.52 |
| Net Income | -600.09 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -557.44 |
| Cash from Investing | -554.39 |
| Cash from Financing | 959.41 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Farallon Capital Partners, L.P. | 5.10 | 24.09 | |
| 13G/A | Janus Henderson Group Plc | 5.50 | 7.65 | |
| 13G/A | Wellington Management Group Llp | 6.83 | -23.39 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 549,142 | 1,901,645 | 28.88 | |
| 562,311 | 1,452,308 | 38.72 | |
| 864,864 | 1,968,846 | 43.93 | |
| 1,121,618 | 3,050,126 | 36.77 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ROIV – Roivant Sciences Ltd. | RPRX – Royalty Pharma plc |
| RPTX – Repare Therapeutics Inc. | RXRX – Recursion Pharmaceuticals, Inc. |
| SANA – Sana Biotechnology, Inc. |
Financial data and stock pages provided by
Fintel.io